Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 1;4(12):e2136798.
doi: 10.1001/jamanetworkopen.2021.36798.

Out-of-Pocket Costs for Colonoscopy After Noninvasive Colorectal Cancer Screening Among US Adults With Commercial and Medicare Insurance

Affiliations

Out-of-Pocket Costs for Colonoscopy After Noninvasive Colorectal Cancer Screening Among US Adults With Commercial and Medicare Insurance

A Mark Fendrick et al. JAMA Netw Open. .

Abstract

This economic evaluation examines whether adult patients in the US who have commercial or Medicare insurance pay out-of-pocket costs associated with follow-up colonoscopy within 6 months of a noninvasive stool-based test.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Fendrick reported serving as a consultant for AbbVie, Amgen, Bayer, Centivo, Community Oncology Association, Covered California, Eli Lilly and Company, EmblemHealth, Exact Sciences Corporation, Freedman HealthCare, GRAIL, Harvard University, Health & Wellness Innovations, Health at Scale Technologies, HealthCorum, Hygieia, Mallinckrodt Pharmaceuticals, MedZed, Merck & Co, Mercer, Montana Health CO-OP, Pair Team, Penguin Pay, Phathom Pharmaceuticals, Risalto Health, Risk International, Sempre Health, state of Minnesota, US Department of Defense, Virginia Center for Health Innovation, Wellth, Wildflower Health, Yale New Haven Health System, and Zansors; reported receiving research support from the Agency for Healthcare Research and Quality, Boehringer Ingelheim, Gary and Mary West Health Policy Center, Arnold Ventures, the Laura and John Arnold Foundation, National Pharmaceutical Council, Patient-Centered Outcomes Research Institute, Pharmaceutical Research and Manufacturers of America, the Robert Wood Johnson Foundation, Michigan Department of Health and Human Services, and Centers for Medicare & Medicaid Services; and reported serving as coeditor of the American Journal of Managed Care, a member of the Medicare Evidence Development & Coverage Advisory Committee, and a partner in V-BID Health. Mss Princic and Wilson reported being employed by IBM Watson Health, which received funding from Exact Sciences Corporation to conduct this study. Dr Miller-Wilson reported being employed by Exact Sciences Corporation. Dr Limburg reported serving as chief medical officer for screening at Exact Sciences Corporation through a contracted services agreement with Mayo Clinic; Dr Limburg and Mayo Clinic have contractual rights to receive royalties through this agreement.

Figures

Figure.
Figure.. Mean Out-of-Pocket Costs of Subsequent Colonoscopy in the 6 Months After Stool-Based Test With and Without Polypectomy, Overall and by Payer

Similar articles

Cited by

References

    1. Zauber AG, Winawer SJ, O’Brien MJ, et al. . Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366(8):687-696. doi:10.1056/NEJMoa1100370 - DOI - PMC - PubMed
    1. Shaukat A, Mongin SJ, Geisser MS, et al. . Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013;369(12):1106-1114. doi:10.1056/NEJMoa1300720 - DOI - PubMed
    1. Davidson KW, Barry MJ, Mangione CM, et al. ; US Preventive Services Task Force . Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(19):1965-1977. doi:10.1001/jama.2021.6238 - DOI - PubMed
    1. Pan Foundation . Issue brief No. 15: food insecurity among older adults. January 2021. Accessed June 6, 2021. https://www.panfoundation.org/app/uploads/2021/02/PAN-Issue-Brief-15.pdf
    1. McBain RK, Cantor JH, Jena AB, Pera MF, Bravata DM, Whaley CM. Decline and rebound in routine cancer screening rates during the COVID-19 pandemic. J Gen Intern Med. 2021;36(6):1829-1831. doi:10.1007/s11606-021-06660-5 - DOI - PMC - PubMed

Publication types